Additional file 2: of Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer

Figure S1. Survival outcomes according to the MTV change. Progression-free survival (A) and overall survival (B) of patients according to the metabolic tumor volume (MTV) reduction ratio (mid-treatment MTV-to-pretreatment MTV). Responders were patients with MTV reduction ratios ≤1.14, while non-responders were patients with MTV reduction ratios > 1.14. (TIF 204 kb)